Flow cytometry confirmed that more than 50% of these particles are CD81-positive, indicating that they are EVs, and more than 50% of these particles are CD19-positive, indicating that they are derived from CLL cells (Figure 1D). Here, CD81 is linked to B-cell chronic lymphocytic leukemia.